BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25982368)

  • 21. The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival.
    Eloranta S; Lambert PC; Andersson TM; Björkholm M; Dickman PW
    Epidemiology; 2014 Sep; 25(5):742-8. PubMed ID: 25036430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal improvements noted in life expectancy of patients with colorectal cancer; a Dutch population-based study.
    Qaderi SM; Andersson TML; Dickman PW; de Wilt JHW; Verhoeven RHA
    J Clin Epidemiol; 2021 Sep; 137():92-103. PubMed ID: 33836257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of colon cancer in the elderly: a population-based study.
    Egenvall M; Schubert Samuelsson K; Klarin I; Lökk J; Sjövall A; Martling A; Gunnarsson U
    Colorectal Dis; 2014 Jun; 16(6):433-41. PubMed ID: 24460639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expected years of life lost for six potentially preventable cancers in the United States.
    Liu PH; Wang JD; Keating NL
    Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival.
    Lemmens V; van Steenbergen L; Janssen-Heijnen M; Martijn H; Rutten H; Coebergh JW
    Acta Oncol; 2010 Aug; 49(6):784-96. PubMed ID: 20429731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loco-regional recurrence from colon cancer: a population-based study.
    Sjövall A; Granath F; Cedermark B; Glimelius B; Holm T
    Ann Surg Oncol; 2007 Feb; 14(2):432-40. PubMed ID: 17139459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating the loss of lifetime function using flexible parametric relative survival models.
    Jakobsen LH; Andersson TM; Biccler JL; El-Galaly TC; Bøgsted M
    BMC Med Res Methodol; 2019 Jan; 19(1):23. PubMed ID: 30691400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
    Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
    Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England.
    Syriopoulou E; Bower H; Andersson TM; Lambert PC; Rutherford MJ
    Br J Cancer; 2017 Oct; 117(9):1419-1426. PubMed ID: 28898233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of revised populations on mortality statistics for the United States, 2000.
    Anderson RN; Arias E
    Natl Vital Stat Rep; 2003 Jun; 51(9):1-24. PubMed ID: 12795490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
    Randén M; Rutqvist LE; Johansson H
    Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.
    Chandanos E; Lindblad M; Jia C; Rubio CA; Ye W; Lagergren J
    Br J Cancer; 2006 Jul; 95(1):118-22. PubMed ID: 16755290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ulcerative colitis and colorectal cancer. A population-based study.
    Ekbom A; Helmick C; Zack M; Adami HO
    N Engl J Med; 1990 Nov; 323(18):1228-33. PubMed ID: 2215606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Life expectancy and expected years of life lost to oral cancer in Taiwan: a nation-wide analysis of 22,024 cases followed for 10 years.
    Huang CC; Ou CY; Lee WT; Hsiao JR; Tsai ST; Wang JD
    Oral Oncol; 2015 Apr; 51(4):349-54. PubMed ID: 25604257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the proportion cured of cancer: some practical advice for users.
    Yu XQ; De Angelis R; Andersson TM; Lambert PC; O'Connell DL; Dickman PW
    Cancer Epidemiol; 2013 Dec; 37(6):836-42. PubMed ID: 24042025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased cancer risk in offspring of women with colorectal carcinoma: a Swedish register-based cohort study.
    Planck M; Anderson H; Bladström A; Möller T; Wenngren E; Olsson H
    Cancer; 2000 Aug; 89(4):741-9. PubMed ID: 10951335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in the Life Expectancy of Patients with Cancer in the United States.
    Devasia TP; Howlader N; Dewar RA; Stevens JL; Mittu K; Mariotto AB
    Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):196-205. PubMed ID: 38015774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors that affect life expectancy of patients with gastric adenocarcinoma.
    Chen WY; Cheng HC; Wang JD; Sheu BS
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1595-600. PubMed ID: 23811250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rise in the number of long-term survivors from different diseases can slow the increase in life expectancy of the total population.
    Ebeling M; Meyer AC; Modig K
    BMC Public Health; 2020 Oct; 20(1):1523. PubMed ID: 33028250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.